07th week of 2015 patent applcation highlights part 39 |
Patent application number | Title | Published |
20150044083 | VARIABLE CAPACITY TYPE VANE PUMP - A variable capacity type vane pump with a first fluid pressure chamber and a second fluid pressure chamber provided at opposite sides of a pivot point of a cam ring includes a control valve for controlling a drive pressure of working fluid introduced from a pump chamber to the second fluid pressure chamber, a suction pressure of the working fluid sucked into the pump chamber is constantly introduced to the first fluid pressure chamber, and the cam ring pivots in a direction to decrease a discharge capacity due to a pressure in the pump chamber acting on an inner peripheral cam surface during an operation to reduce the drive pressure, whereas the cam ring pivots in a direction to increase the discharge capacity during an operation to increase the drive pressure. | 2015-02-12 |
20150044084 | METHODS FOR FABRICATING GRADIENT ALLOY ARTICLES WITH MULTI-FUNCTIONAL PROPERTIES - Systems and methods for fabricating multi-functional articles comprised of additively formed gradient materials are provided. The fabrication of multi-functional articles using the additive deposition of gradient alloys represents a paradigm shift from the traditional way that metal alloys and metal/metal alloy parts are fabricated. Since a gradient alloy that transitions from one metal to a different metal cannot be fabricated through any conventional metallurgy techniques, the technique presents many applications. Moreover, the embodiments described identify a broad range of properties and applications. | 2015-02-12 |
20150044085 | FERRITIC STAINLESS STEEL SHEET - To provide a ferritic stainless steel sheet which has high scale spalling even at a high temperature around 1000° C. Provided is a ferritic stainless steel sheet having excellent Mn-containing oxide film-forming ability and scale spalling ability, containing, in terms of mass %: C: 0.001 to 0.020%, N: 0.001 to 0.020%, Si: 0.10 to 0.40%, Mn: 0.20 to 1.00%, Cr: 16.0 to 20.0%, Nb: 0.30 to 0.80%, Mo: 1.80 to 2.40%, W: 0.05 to 1.40%, Cu: 1.00 to 2.50%, and B: 0.0003 to 0.0030%, in which the above-mentioned components are contained satisfying the formula (1) below, and the balance is composed of Fe and inevitable impurities. At least one of N, Al, V, Mg, Sn, Co, Zr, Hf, and Ta may be added in a predetermined content range. | 2015-02-12 |
20150044086 | STEEL WIRE ROD OR STEEL BAR HAVING EXCELLENT COLD FORGEABILITY - A steel wire rod or steel bar as hot-rolled, including: by mass %: C: 0.1 to 0.6%, Si: 0.01 to 1.5%, Mn: 0.05 to 2.5%, Al: 0.015 to 0.3%, and N: 0.0040 to 0.0150%, and P: limited to 0.035% or less and S: limited to 0.025% or less, and the balance substantially consisting of iron and unavoidable impurities, wherein a depth of d (mm) from the surface of the surface layer region with 20 HV 0.2 or more higher, relative to HV 0.2 that is the average hardness in the region where the depth from the surface is from sectional radius R×0.5 (mm) to the center satisfies the formula (1); the steel structure of the surface layer region has a ferrite fraction of 10% or less by area ratio, with the balance being one or two or more of martensite, bainite and pearlite; the steel structure where the depth from the surface is from the sectional radius R×0.5 (mm) to the center is ferrite-pearlite or ferrite-bainite; and the surface roughness Ra in the circumferential direction when scales adhering to the surface have been removed is 4 μm or less. | 2015-02-12 |
20150044087 | METHOD FOR PRODUCING MOLD STEEL, MOLD STEEL, METHOD OF PRODUCING PRE-HARDENED MOLD MATERIAL, AND PRE-HARDENED MOLD MATERIAL - A method of producing a mold steel, the method including a first process of preparing a molten steel A that is obtained after vacuum refining and has a component composition including from 0.005% to 0.1% by mass of C, from 1.0% to 5.0% by mass of Ni, from 3.0% to 8.0% by mass of Cr, more than 0% but less than or equal to 2.0% by mass of Mo, more than 0% but less than or equal to 3.5% by mass of Cu, and more than 0% but less than or equal to 2.0% by mass of Al, in which an amount of O is 0.005% by mass or less and an amount of N is 0.03% by mass or less; a second process of reducing the amount of O and the amount of N in the molten steel A, by slag refining the molten steel A, to obtain a molten steel B; and a third process of casting the molten steel B, is provided. | 2015-02-12 |
20150044088 | Creep-Resistant, Cobalt-Free Alloys for High Temperature, Liquid-Salt Heat Exchanger Systems - An essentially Fe- and Co-free alloy is composed essentially of, in terms of weight percent: 6.0 to 7.5 Cr, 0 to 0.15 Al, 0.5 to 0.85 Mn, 11 to 19.5 Mo, 0.03 to 4.5 Ta, 0.01 to 9 W, 0.03 to 0.08 C, 0 to 1 Re, 0 to 1 Ru, 0 to 0.001 B, 0.0005 to 0.005 N, balance Ni, the alloy being characterized by, at 850° C., a yield strength of at least 25 Ksi, a tensile strength of at least 38 Ksi, a creep rupture life at 12 Ksi of at least 25 hours, and a corrosion rate, expressed in weight loss [g/(cm | 2015-02-12 |
20150044089 | COPPER/ZINC ALLOYS HAVING LOW LEVELS OF LEAD AND GOOD MACHINABILITY - The free-cutting copper alloy according to the present invention contains a greatly reduced amount of lead in comparison with conventional free-cutting copper alloys, but provides industrially satisfactory machinability. The free-cutting alloys comprise 69 to 79 percent, by weight, of copper, 2.0 to 4.0 percent, by weight, of silicon, 0.02 to 0.4 percent, by weight, of lead, and the remaining percent, by weight, of zinc. | 2015-02-12 |
20150044090 | Strength Evaluation Method of Die Casting Product and Die Casting Product - There are provided a strength evaluation method of a die casting product capable of appropriately evaluating the strength of the die casting product, and a die casting product in which the strength is evaluated by the strength evaluation method. A breakage test is performed by a simple strength tester after casting, and then, a strength reduction ratio is estimated based on an area ratio of cold flakes in a broken surface obtained by broken surface observation. Alternatively, ultrasonic flaw detection is performed for an internal defect in a predetermined range of a high stress portion of the die casting product, calculated by stress analysis in advance, and the die casting product is evaluated to have a predetermined strength when a defect ratio obtained by dividing a total area of the internal defect in the predetermined range by a total defect detection area is less than or equal to a predetermined value. | 2015-02-12 |
20150044091 | MICROWAVE STERILIZATION OF PHARMACEUTICAL CYANOACRYLATE ESTERS COMPOSITIONS - A method for sterilizing a cyanoacrylate composition comprises exposing it to microwaves. The method can further comprise post-heating the composition after microwave exposure, and/or cooling the composition after post-heating it. In addition, a system for sterilizing a cyanoacrylate composition comprises a sterilizing chamber, a microwave generator. The system can further comprise an infrared thermometer, a post-heating chamber, a heater thermometer, a cooling mechanism, and/or a belt. In some embodiments, the belt is configured to move sample vials containing cyanoacrylate to and from the sterilizing chamber, and to and from the post-heating chamber. | 2015-02-12 |
20150044092 | LOCAL THERMAL ACTUATION OF MATERIAL SURFACES VIA MICRO- AND NANOWIRE HEATING FOR THE PREVENTION OF CELLULAR ATTACHMENT AND BIOLOGICAL FOULING - The invention relates in various embodiments to a composite useful as e.g. a medical implant device, and a method of treating fouling, including biofouling as may occur on an implant. The composite comprises a matrix phase and a patterned phase that comprises an energetically activatable wire intermixed with the matrix phase, the wire when energetically activated, which includes thermal activation, causes modification of at least a portion of the matrix phase to treat fouling that might otherwise occur. The method of treating biofouling may be practiced on a patent while the medical implant of the invention is in situ. | 2015-02-12 |
20150044093 | SYSTEMS AND CONTAINERS FOR STERILIZING A FLUID - A system for sterilizing a fluid includes a fluid source and a sterilization container bounding a fluid flow path that is in fluid communication with the fluid source. The sterilization container is comprised of one or more polymeric walls. An electron beam generator is configured to direct an electron beam through at least a portion of the fluid flow path of the sterilization container, the electron beam being sufficient to sterilize a fluid within the fluid flow path. | 2015-02-12 |
20150044094 | GAS STERILIZATION/DISINFECTION SYSTEM AND METHOD FOR FLUID CONDUITS - The present disclosure pertains to a ventilator treatment system configured to sterilize and/or disinfect a fluid pathway through a ventilator by providing a forced flow of treatment gas to the ventilator. Ventilators are frequently contaminated with bacteria and viruses during normal use. When a ventilator is moved from one patient to the next, there is a risk of contaminating the new patient with a pathogen from the previous patient. The application of treatment gas is especially practical for sanitizing hard to access surfaces such as those found in the cavities and conduits (the fluid pathway) of a ventilator. A treatment gas such as, for example, ozone, converts back to oxygen and has a short half life, which can be further reduced with humidity, heat, or inexpensive destruct catalysts. This disclosure is applicable to any medical device with a fluid pathway that can become contaminated, provided the materials in the fluid pathway of the medical device are compatible with the sterilization and/or disinfection gas. In one embodiment, the ventilator sterilization system comprises one or more of a treatment gas flow generator, a gas circuit, a user interface, one or more sensors, a treatment gas remediation system, an exhaust port, one or more valves, a processor, electronic storage, and/or other components. | 2015-02-12 |
20150044095 | Plasma Powder Sterilization Apparatus and Methods - Systems and methods for plasma sterilization are described. The sterilization method includes placing a substance to be sterilized in a rotating chamber (e.g., drum) and exposing the substance to a radio frequency (RF) plasma. The mixing of the substance and plasma is further promoted by generating a magnetic field that produces a force on the substance in a direction opposite to the rotational direction of the chamber. In other aspects, the chamber may have a gas permeable wall. In addition, the substance may be exposed to acoustic shock waves produced by a modulating RF generator. | 2015-02-12 |
20150044096 | AUTOMATIC ANALYZER - Provided is an automatic analyzer capable of performing measurements efficiently. The automatic analyzer comprises: a first reagent disk on which reagent packs each storing a reagent to be used for a reaction are placed; a second reagent disk; and a reagent pack transfer mechanism which transfers the reagent packs between the first reagent disk and the second reagent disk. A judgment unit and a drive control unit of a computer operate to transfer a reagent pack that has been placed on the second reagent disk to the first reagent disk using the reagent pack transfer mechanism, perform at least quality control measurement out of the calibration and the quality control measurement with the reagent stored in the reagent pack transferred to the first reagent disk, and thereafter return the reagent pack to the second reagent disk using the reagent pack transfer mechanism. | 2015-02-12 |
20150044097 | FILTRATION DEVICE FOR ASSAYS - A device and method for filtering blood is disclosed herein. The device can filter blood and attach analytes within the blood to magnetic particles. The analytes can then be strongly bound to an analyzing device by a magnetic force. The analytes can then be counted by the analyzing device and the result can be displayed. | 2015-02-12 |
20150044098 | HYPERSPECTRAL IMAGING SYSTEMS, UNITS, AND METHODS - A hyperspectral imaging system, including: at least one hyperspectral imaging unit, including: at least one lens configured to direct light scattered by, reflected by, or transmitted through a target medium to at least one hyperspectral filter arrangement configured to separate the light into discrete spectral bands; an imaging sensor to: receive the discrete spectral bands from the at least one hyperspectral filter arrangement; detect light by a plurality of pixels for each of the spectral bands; and generate electrical signals based at least in part on at least a portion of the light; and at least one image processor in communication with the at least one imaging sensor and configured to generate hyperspectral image data associated with the target medium; and at least one processor configured to determine biological data based at least partially on at least a portion of the hyperspectral image data. | 2015-02-12 |
20150044099 | MEASURING DEVICE, DIALYSIS END CONDITION DETERMINING DEVICE, AND DIALYSIS PROGRESS PRESENTING DEVICE - A measuring device ( | 2015-02-12 |
20150044100 | DEGRADANT CONCENTRATION MEASUREMENT DEVICE AND ACIDIC GAS REMOVAL DEVICE - A degradant concentration measurement device | 2015-02-12 |
20150044101 | Air Purifying Apparatus Having Shuntable Air Duct - An air purifying apparatus according to an embodiment includes a body having first and second conduits through which a flow of air is generated from an air inlet to an air outlet, an ultraviolet light emitting diode part and a first filter part disposed within the first conduit, and a second filter part disposed within the second conduit. | 2015-02-12 |
20150044102 | HYDROGEN GENERATION APPARATUS - A hydrogen generation apparatus is configured to be supplied with a raw material containing a hydrocarbon component and generate a hydrogen-containing fuel gas. The hydrogen generation apparatus includes: a reformer configured to cause a reforming reaction of a mixed gas of the raw material and steam; a combustor configured to combust a combustible gas to heat the reformer; a hydrodesulfurizer configured to be supplied with heat from the reformer, and cause a reaction between sulfur in the raw material that is to be supplied to the reformer and hydrogen to remove the sulfur from the raw material; a first heat insulating material disposed between the hydrodesulfurizer and the reformer; and a heat equalizing plate disposed between the hydrodesulfurizer and the first heat insulating material. | 2015-02-12 |
20150044103 | Perforated Mixing Pipe With Swirler - An aftertreatment system may include an exhaust pipe and a mixing pipe. The exhaust pipe receives exhaust gas from an engine. The mixing pipe is disposed in the exhaust pipe and may include a tubular portion and a plurality of blades extending from a longitudinal end of the tubular portion. The tubular portion may include a plurality of openings extending through inner and outer diametrical surfaces of the tubular portion. The tubular portion and the plurality of blades may define an integrally formed unitary body. | 2015-02-12 |
20150044104 | WASTE GAS TREATMENT APPARATUS - A waste gas treatment apparatus includes a waste gas treatment trough and a partition. The waste gas treatment trough is formed with a waste gas inlet and a waste gas outlet. An annular heater is provided in the waste gas treatment trough. A heating rod is provided in the annular heater. A heating chamber is formed between the annular heater and the heating rod. The partition is disposed between the annular heater and the heating rod. The heating chamber is partitioned to form a gas channel through the partition. The gas channel has an inlet end communicating with the waste gas inlet and an outlet end communicating with the waste gas outlet through the heating chamber. The present invention can prolong the time that the harmful waste gas is heated and purified in the heating chamber to enhance the purification efficiency of the harmful waste gas. | 2015-02-12 |
20150044105 | PLASMA CHEMICAL DEVICE FOR CONVERSION OF HYDROCARBON GASES TO LIQUID FUEL - A system with a non-thermal, repetitively-pulsed gliding discharge reactor for converting gaseous hydrocarbons into liquid fuels efficiently. The system optionally contains a gas separator for removing non-hydrocarbon components from the gaseous hydrocarbon feed to improve efficiency of the system. The system may optionally reclaim hydrogen gas from the product gas for storage, transportation or power generation. | 2015-02-12 |
20150044106 | MULTI-STAGE PLASMA REACTOR SYSTEM WITH HOLLOW CATHODES FOR CRACKING CARBONACEOUS MATERIAL - Disclosed is a multi-stage plasma reactor system with hollow cathodes for cracking carbonaceous material with each stage comprising: hollow cathodes and hollow anodes cooled by recycling cooling medium or refrigerant; working gas inlet(s); inlet(s) of carbonaceous material and carrier gas as feedstock; reaction tubes in connection with the anode or cathode, in addition, the reactor system also comprises: at least one inlet(s) of quench medium located lower portion of last one of the reaction tubes; and at least one outlet(s) of quenched products and gases located on bottom or lower portion of last one of the reaction tubes, wherein chambers are formed between the first hollow cathode or the hollow cathode used as the reaction tube of any stage and the anode so as to generate plasma gas and/or electric arc therein, generated plasma gas jet fully contacts and efficiently mixes with the carbonaceous material and carrier gas as feedstock and/or volatiles caused by pyrolysis within or nearby highest temperature region of the chambers, and pyrolysis of the carbonaceous material and/or gas-phase reaction of volatiles are occurred. The present reactor system has excellent energy efficiency and higher cracked products yield. | 2015-02-12 |
20150044107 | PRODUCTION OF RENEWABLE BIOFUELS - Renewable fuels are produced in commercial quantities and with enhanced efficiency by integrating a bio-oil production system with a conventional petroleum refinery so that the bio-oil is co-processed with a petroleum-derived stream in the refinery. The techniques used to integrate the bio-oil production system and conventional petroleum refineries are selected based on the quality of the bio-oil and the desired product slate from the refinery. | 2015-02-12 |
20150044108 | HYDROGEN PRODUCING FUEL CARTRIDGE - Disclosed herein is a method of producing hydrogen, including selectively applying heat to a fuel within a canister thermally insulated and inside a cartridge, firing fuel with heating elements to facilitate decomposition and release hydrogen, and, removing said hydrogen from said cartridge via a fluid communication means. | 2015-02-12 |
20150044109 | MICROENCAPSULATION PROCESS OF SERTOLI CELLS, MICROCAPSULES OBTAINED AND USE FOR TREATMENT OF TYPE I DIABETES MELLITUS - An apparatus for production of microcapsules includes a volumetric pump configured to deliver a polysaccaridic suspension through a catching tube. A needle-type element is configured to receive the suspension through the catching tube, and the needle-type element has a button hole opening in a lateral wall thereof and an output hole that outputs the suspension. The button hole opening receives a pressure fluid current. A pressure regulator is coupled to the button hole opening to regulate the pressure fluid current to interrupt a suspension flow and obtain microdroplets of homogeneous size exiting the output hole. The microdroplets are received in a receiving container in a solution including divalent cations or polycationic substances to form a gel such that homogeneous microcapsules are formed. | 2015-02-12 |
20150044110 | MICROFLUIDIC DEVICE WITH HYDROPHOBIC SURFACE MODIFICATION LAYER AND MANUFACTURING METHOD THEREOF - A microfluidic device includes a support body having a first surface and a second surface opposite to one another. The first surface is hydrophilic. A surface modification layer extends over the first surface of the support body. At least one opening is formed to extend through the surface modification layer and expose a portion of the first surface. The surface modification layer is hydrophobic. In particular, the surface modification layer is made of a photodefinible material chosen from among: an epoxy resin, a polyamide, and a photocurable siloxane-based polymer. The openings are functionalized using probe molecules designed to bind with specific target molecules to be detected. | 2015-02-12 |
20150044111 | PIPETTING MACHINE HAVING A DISPOSAL CONTAINER - The invention relates to a metering apparatus ( | 2015-02-12 |
20150044112 | METHOD FOR OPERATING FLASH VESSEL - The present invention is such that, with H1 being the height from a slurry outlet to a control liquid level, H2 being the height from the control liquid level to the top of a flash vessel, and being the diameter of the flash vessel, 0.35D≦H1≦0.45D, and 0.75D≦H2≦0.85D, and at least one liquid level sensor detects a slurry liquid surface at a control liquid level; when the liquid level sensor detects a slurry liquid surface which has risen, a slurry discharge valve installed on a slurry discharge pipe derived from the flash vessel is opened; and when the liquid level sensor detects a slurry liquid surface which has fallen, the slurry discharge valve is closed, whereby opening and closing of the valve is appropriately controlled thereby to reduce troubles with a steam discharge pipe, the slurry discharge pipe, and the slurry discharge valve. | 2015-02-12 |
20150044113 | Potash Processing with Mechanical Vapor Recompression - A potash-extraction system and method for extracting potash from a brine containing potash without the use of water-consuming evaporation ponds or additional chemicals is disclosed. The potash processing system uses a mechanical-vapor recompression (“MVR”) cycle to separate salt and then potash from a sylvinite brine containing salt and potash. In embodiments, the latent heat recovered from condensing vapor may be used to boil the brine to precipitate some salt and remove some water (in the form of water vapor) from the brine. The remaining potash-concentrated brine may then be cooled to precipitate potash from the solution. The precipitated potash may then be further processed for final use. | 2015-02-12 |
20150044114 | ACID GAS ABSORBENT, ACID GAS REMOVAL METHOD, AND ACID GAS REMOVAL DEVICE - An acid gas absorbent according to an embodiment includes at least one kind of amino acid salt represented by the following general formula (1). | 2015-02-12 |
20150044115 | WASTE DISPOSAL - The waste disposal system disclosed herein includes a chamber operated at high ampere and low voltage, the chamber configured to inject smoke on a stream of free radicals. In one implementation, the stream of free radicals is generated from a plasma igniter and the smoke is generated from waste products, such as hospital waste products. | 2015-02-12 |
20150044116 | Method for removing contaminants from exhaust gases - In a method for removing a portion of contaminants, such as nitrogen oxides, from an exhaust gas stream of a combustion process, the exhaust gas stream is conveyed through a gas distributor at an inlet of a wet horizontal spray scrubber. A distributor separates the gas stream into a plurality of spaced apart partitioned gas streams. The gas stream is partitioned in the chamber of the scrubber without the need for any physical partitions or obstructions positioned in the chamber. A preselected number of the partitioned gas streams are mixed with ozone to oxidize the contaminants in the gas streams. The oxidized gas streams are then sprayed with an aqueous medium to capture the oxidized contaminants and remove them from the treated gas streams. The treated gas streams are then recombined with the untreated gas streams. Excess ozone present in the treated gas streams is consumed by oxidation of contaminants in the untreated gas streams before the combined gas stream is released to the atmosphere. The partitioned gas streams selected for mixing with ozone directly correlates to the amount of nitrogen oxides that are desired to be removed from the exhaust gas stream. | 2015-02-12 |
20150044117 | CAVITAND COMPOSITIONS AND METHODS OF USE THEREOF - Cavitand compositions that comprise void spaces are disclosed. The void spaces may be empty, which means that voids are free of guest molecules or atoms, or the void spaces may comprise guest molecules or atoms that are normally in their gas phase at standard temperature and pressure. These cavitands may be useful for industrial applications, such as the separation or storage of gasses. Novel cavitand compounds are also disclosed. | 2015-02-12 |
20150044118 | LOW-CHLORIDE LIPF6 - The present invention relates to a process for preparing low-chloride LiPF | 2015-02-12 |
20150044119 | COLD FILAMENT IGNITION SYSTEM AND METHOD OF SILICON RODS - A method and system of igniting one or more filaments for silicon production includes applying an output voltage to the one or more filaments using a transformer connected with the one or more filaments. In addition, the method includes supplying, in combination with the application of the output voltage, a current to a primary winding of the transformer via a choke to limit the current to a first predetermined current threshold range. The combination of the supplied current and applied output voltage allows a predetermined output range to be generated from a power supply device initially required to ignite the one or more filaments. | 2015-02-12 |
20150044120 | METHODS AND SYSTEMS FOR PRODUCING AND PROCESSING SYNGAS IN A PRESSURE SWING ADSORPTION UNIT AND MAKING AMMONIA THEREFROM - Methods and systems for making ammonia are provided. The method can include converting carbon monoxide in a first syngas to carbon dioxide to produce a shifted syngas. At least a portion of the carbon dioxide can be separated from the shifted syngas to produce a carbon dioxide-lean syngas. Carbon monoxide and/or carbon dioxide in the carbon dioxide-lean syngas can be converted to methane to produce a methanated first syngas. A second syngas can be separated to produce a purified second syngas and a waste gas. The methanated first syngas and the purified second syngas can be combined to produce an ammonia feedstock. The ammonia feedstock can have a hydrogen to nitrogen molar ratio of about 3.5:1 to about 2.5:1. At least a portion of the hydrogen and nitrogen in the ammonia feedstock can be reacted to produce an ammonia product. | 2015-02-12 |
20150044121 | METHODS AND SYSTEMS FOR MAKING AMMONIA IN A DOUBLE AMMONIA CONVERTER SYSTEM - Methods and systems for making ammonia are provided. The method can include heating a first compressed syngas to produce a heated first syngas. The heated first syngas and a second compressed syngas can be combined to produce a combined syngas. The combined syngas can be reacted within a first ammonia converter and a second ammonia converter to produce an ammonia product. Heat from the ammonia product can be transferred to a first heat transfer medium to produce a first cooled product and a second heat transfer medium. Heat from the first cooled product can be transferred to a third heat transfer medium to produce a second cooled product. Heat from the second cooled product can be transferred to the combined syngas to produce a third cooled product. The third cooled product can be separated to produce a purified ammonia product and a recycle gas. | 2015-02-12 |
20150044122 | PRESSURE-REGULATED MULTI-REACTOR SYSTEM - A device and a method are provided for reacting a starting material in at least two reactors connected to each other, including the reacting of the starting material in a first reactor to a first product, removing the first product from the first reactor using a jet pump, wherein a negative pressure zone of the jet pump is operationally connected to the first reactor, so that the first product of the first reactor moves through the negative pressure zone in a propulsion jet of a propulsion medium of the jet pump, conducting the propulsion medium having the first product into a second reactor, wherein the first product is allowed to react into a second product, separating the second product from the propulsion medium and discharging the separated second product. | 2015-02-12 |
20150044123 | THERMOCHEMICAL REACTOR SYSTEMS AND METHODS - Thermochemical reactor systems that may be used to produce a fuel, and methods of using the thermochemical reactor systems, utilizing a reactive cylindrical element, an optional energy transfer cylindrical element, an inlet gas management system, and an outlet gas management system. | 2015-02-12 |
20150044124 | METHOD FOR RECOVERING LITHIUM CARBONATE - A method and arrangement for recovering lithium carbonate from a raw material containing lithium, which method comprises pulping ( | 2015-02-12 |
20150044125 | ACRYLIC-FIBER FINISH FOR CARBON-FIBER PRODUCTION, ACRYLIC FIBER FOR CARBON-FIBER PRODUCTION, AND CARBON-FIBER PRODUCTION METHOD - An acrylic-fiber finish for carbon fiber production is prepared into a stable emulsion and applied to a carbon-fiber precursor to prevent gumming up of finish components in precursor production and carbon fiber fusing in baking process. The acrylic-fiber finish is used for carbon-fiber production and includes a modified silicone having a modifying group containing a nitrogen atom and an acidic phosphate ester represented by the following chemical formula (1). | 2015-02-12 |
20150044126 | HYDROGEN SULFIDE GAS PRODUCTION PLANT AND METHOD FOR RECOVERING AND USING WASTE HYDROGEN SULFIDE GAS - An object is to provide a hydrogen sulfide gas production plant that can recover discharged waste hydrogen sulfide gas and efficiently supply the gas to a process plant where processing is conducted by using hydrogen sulfide gas, and also provide a method for recovering and using the waste hydrogen sulfide gas by the hydrogen sulfide gas production plant. In the present invention, the hydrogen sulfide gas production plant is provided with a pipe that recovers the waste hydrogen sulfide gas discharged from the hydrogen sulfide gas production plant and that has one end connected to the process plant where the hydrogen sulfide gas is used, and the discharged waste hydrogen sulfide gas is recovered and the recovered waste hydrogen sulfide gas is supplied to the process plant through the pipe. | 2015-02-12 |
20150044127 | HYDROPHOBISED CALCIUM CARBONATE PARTICLES - The present invention relates to a process for the reduction of pitch in an aqueous medium generated in a papermaking or pulping process, comprising the following steps: a) providing an aqueous medium comprising pitch generated in a papermaking or pulping process; b) providing a ground calcium carbonate and/or a precipitated calcium carbonate; c) providing a hydrophobising agent selected from an aliphatic carboxylic acid having between 5 and 24 carbon atoms; d) contacting the ground calcium carbonate and/or the precipitated calcium carbonate of step b) with the hydrophobising agent of step c) for obtaining a hydrophobised ground calcium carbonate and/or a hydrophobised precipitated calcium carbonate; and e) contacting the aqueous medium provided in step a) with the hydrophobised ground calcium carbonate and/or the hydrophobised precipitated calcium carbonate obtained in step d), to the use of a hydrophobised ground calcium carbonate and/or a hydrophobised ground calcium carbonate for reducing the amount of pitch in an aqueous medium as well as to a hydrophobised ground calcium carbonate and/or a hydrophobised ground calcium carbonate and a composite of hydrophobised ground calcium carbonate and/or hydrophobised ground calcium carbonate and pitch. | 2015-02-12 |
20150044128 | DEACIDIFICATION PROCESS AND APPARATUS THEREOF - A deacidification apparatus and a deacidification process using the apparatus are disclosed. The deacidification apparatus includes a deacidification furnace, of which a furnace upper section, a furnace middle section and a furnace lower section are provided in upper, middle and lower portions respectively, wherein a gas-solid mixture inlet ( | 2015-02-12 |
20150044129 | METHOD FOR PROCESSING COKE OVEN GAS - The invention relates to a method for processing coke oven gas, said coke oven gas containing hydrogen, wherein the coke oven gas is at least partially integrated into a method for producing dimethyl ether in conjunction with a gas containing carbon monoxide and/or carbon dioxide, whereby a DME-containing product gas is formed. At the outset of the method for the formation of dimethyl ether, a ratio of hydrogen to carbon monoxide, weighted with the carbon dioxide concentration (formula (I)), of 0.9 to 1.1 is set, wherein the DME-containing product gas is integrated into a method for converting dimethyl ether to olefins, whereby an olefin-containing product gas is formed, and wherein olefins, in particular ethylene and/or propylene, is/are separated from the olefin-containing product gas by means of separating methods. | 2015-02-12 |
20150044130 | METAL DOPED ZEOLITE MEMBRANE FOR GAS SEPARATION - The present invention discloses composite inorganic membranes, methods for making the same, and methods of separating gases, vapors, and liquids using the same. The composite zeolite membrane is prepared by TS-1 zeolite membrane synthesis, and subsequent palladium doping. In the composite zeolite membrane synthesis, two different methods can be employed, including in-situ crystallization of one or more layers of zeolite crystals an a porous membrane substrate, and a second growth method by in-situ crystallization of a continuous second layer of zeolite crystals on a seed layer of MFI zeolite crystals supported on a porous membrane substrate. The membranes in the form of disks, tubes, or hollow fibers have high gas selectivity over other small gases, very good impurity resistance, and excellent thermal and chemical stability over polymer membranes and other inorganic membranes for gas, vapor, and liquid, separations. | 2015-02-12 |
20150044131 | HYDROGEN PRODUCING FUEL CARTRIDGE AND METHODS FOR PRODUCING HYDROGEN - In aspects of the disclosure, a fuel cartridge wherein the fuel is in a powdered form is admixed with inert materials such as alumina or other ceramics to improve thermal conductivity. Said cartridge having fuel zones, heating zones, and controllers to selectively heat fuel zones and thereby generate hydrogen via decomposition of fuel is disclosed. | 2015-02-12 |
20150044132 | METHOD OF INJECTING AND REACTING SUPER-CRITICAL PHASE CARBON DIOXIDE WITHOUT PRESSURE LOSS - Disclosed is provided a method of injecting and reacting super-critical phase CO | 2015-02-12 |
20150044133 | PREPARATION OF HIGH-SILICA CHA-TYPE MOLECULAR SIEVES USING A MIXED TEMPLATE - CHA-type molecular sieves are prepared using a N,N,N-trimethyl-1-adamantammonium cation structure directing agent in conjunction with a N,N-dimethyl-3,5-dimethylpiperidinium cation structure directing agent. | 2015-02-12 |
20150044134 | COMPOSITIONS, METHODS AND KITS FOR TREATMENT OF CANCER AND AUTOIMMUNE DISEASES - The present invention is directed to fusion proteins having an IL-21 cytokine portion and an anti-CD20 antibody portion, and methods of using such fusion proteins. The invention also provides pharmaceutical compositions and kits utilizing the IL-21-anti-CD20 fusion proteins. In particular, the methods, kits and compositions of the invention are useful in the treatment of cancer and autoimmune diseases. | 2015-02-12 |
20150044135 | DUAL FUNCTION MARKERS FOR DIAGNOSTICS AND THERAPEUTICS FOR UPPER GASTROINTESTINAL TRACT PRECANCER - The invention described herein relates to the detection, diagnosis, and treatment of intestinal metaplasias that develop to esophageal, gastric, and pancreatic adenocarcinoma. The stem cells and differentiated cells of these intestinal metaplasias show high expression of CDH17 as well as other proteins. The invention also includes a clonal population of Barrett's esophagus stem cells as well as the stem cells of the surrounding normal epithelia and methods of using them for the detection, diagnosis, and treatment of Barrett's esophagus. | 2015-02-12 |
20150044136 | Ophthalmological treatment for michobial infections - The invention described herein relates to the composition of a liquid in which a silver ion moiety can act as a preservative as well as an astringent for the inhibition of microbial infections of the eye. | 2015-02-12 |
20150044137 | NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE - Neutralizing antibodies that specifically bind to HIV-1 gp120 and antigen binding fragments of these antibodies are disclosed. Nucleic acids encoding these antibodies, vectors and host cells are also provided. Methods for detecting HIV using these antibodies are disclosed. In addition, the use of these antibodies, antigen binding fragment, nucleic acids and vectors to prevent and/or treat an HIV infection is disclosed. | 2015-02-12 |
20150044138 | METHOD FOR IMPROVING FUNCTIONAL SYNAPTIC CONNECTIVITY - The invention relates to a composition comprising: (i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof; and (ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof, for use in preserving or improving functional synaptic connectivity and/or preserving brain network organization in a subject in need thereof. | 2015-02-12 |
20150044139 | Method of Treatment or Prevention of Hair Loss or for the Enhancement of Hair Growth - The present application relates to use of a Midkine family protein for growing hair on a mammal, or in the manufacture of a medicament for growing hair on a mammal, especially for treatment or prevention of different forms of alopecia. | 2015-02-12 |
20150044140 | PROTEASE-RESISTANT COMPOUNDS USEFUL AS SHUTTLES THROUGH THE BLOOD-BRAIN BARRIER AND SHUTTLE-CARGO CONSTRUCTS - The peptides of formula (I) R | 2015-02-12 |
20150044141 | SYNTHESIS AND APPLICATION OF NOVEL IMAGING AGENTS CONJUGATED TO DPA 713 ANALOGS FOR IMAGING INFLAMMATION - The present invention provides analog compounds of DPA-713 which specifically bind the translocator protein (TSPO), which is upregulated in activated leukocytes, some malignant tumors and tissues involved in steroid biogenesis. These compounds are linked via a linking moiety to a variety of imaging agents, including, for example, near infra-red dyes. The compounds of the present invention are useful for both pre-clinical near-IR fluorescence imaging (NIRF) and use in optically-guided interventions including NIRF endoscopy. Methods of use in diagnosis and treatment of TSPO related disease are also provided. | 2015-02-12 |
20150044142 | FLUORESCENT PHOSPHOLIPID ETHER COMPOUNDS, COMPOSITIONS, AND METHODS OF USE - The invention generally relates to novel fluorescent phospholipid compounds, compositions comprising these compounds, and diagnostic methods utilizing these compounds. A preferred compound of the present invention has the following structural formula: | 2015-02-12 |
20150044143 | FLUORESCENT MEMBRANE INTERCALATING PROBES AND METHODS FOR THEIR USE - The invention relates to a family of dyes which fluoresce in the UV-VIS, far red and near infrared wavelengths of the spectrum and possess asymmetric lipophilic alkyl chains. The dyes of the invention are soluble in commercially available membrane staining dyes, are useful as probes for rapidly staining lipophilic structures such as membranes in cells or isolated from cells, and are well-retained therein. Methods of utilizing the dyes to detect stained cells both in vivo and in vitro are also disclosed. | 2015-02-12 |
20150044144 | DISINFECTANT SOLUTION - The present invention relates to a disinfectant solution, comprising an oxidative and reductive potential (ORP) solution and a colorant. A disinfectant article, a method of forming the disinfectant solution and use of the disinfectant solution are also provided. | 2015-02-12 |
20150044145 | MATERIALS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS AND FOR INDUCTION OF ION SECRETION - The present invention provides materials and methods for inducing ion secretion and/or for treating cystic fibrosis. In one embodiment, the composition comprises glucose and/or a non-metabolizable glucose analog and/or non-structural protein (NSP4), a NSP4 peptide, or a NSP4 toxoid as the active ingredient, formulated with pharmaceutically-acceptable carriers. In a preferred embodiment, the composition is in a form of an aerosol preparation for intranasal and/or pulmonary administration, and is used to stimulate chloride and fluid secretion in nasal, tracheal and/or bronchial epithelium. | 2015-02-12 |
20150044146 | Replacement Therapy for Dental Caries - The invention provides recombinant | 2015-02-12 |
20150044147 | COMPOSITION FOR MANAGEMENT OF PERIODONTAL DISEASE - The composition for management of periodontal diseases includes a gel matrix having a polymer system and a plurality of microspheres dispersed in the polymer system. The polymer system contains about one-half a dose of medicament, while the microspheres contain the remainder. Upon administration of the composition into the periodontal cavity, the medicament in the polymer system provides an initial therapeutic benefit, while the remainder of the medication is released over time via degradation of the microspheres. This biphasic pattern of medicament delivery provides increased efficacy of the medicament through sustained delivery of the same. | 2015-02-12 |
20150044148 | Method for Treating Capillary Hemangiomas - The invention relates to a method of treating capillary hemangiomas in a human in need thereof by topically administering an effective amount of one or more alpha-2 adrenergic receptors agonist to the site of the capillary hemangiomas on the skin of the human. | 2015-02-12 |
20150044149 | ARYL SUBSTITUTED PROPENOIC AMIDES AND ESTERS - The present disclosure relates, according to some embodiments, to molecules, including substituted propenoic amides (e.g., aryl substituted propenoic amides), that may receive excited state energy from light-absorbing molecules. According to some embodiments, the present disclosure relates to molecules, including substituted propenoic amides (e.g., aryl substituted propenoic amides), that may quench, dissipate, and/or otherwise resolve excited state energy (e.g., as heat). | 2015-02-12 |
20150044150 | COMPOSITIONS AND METHODS FOR UV-CURABLE COSMETIC NAIL COATINGS - The present disclosure relates generally to compositions for natural and artificial nail coatings, and particularly, but not by way of limitation, to polymerizable compositions that provide improved adhesion-promoting and improved solvent-susceptibility. | 2015-02-12 |
20150044151 | REMOVABLE COLOR LAYER FOR ARTIFICIAL NAIL COATINGS AND METHODS THEREFORE - The present disclosure relates to a nail coating system comprising a basecoat, a color layer, and a topcoat. The system of the present disclosure may be applied to natural and/or pre-existing artificial nail coatings. The present disclosure relates generally to compositions for natural and artificial nail coatings, and particularly, but not by way of limitation, to polymerizable compositions and color layers polymerized therefrom. The disclosure further relates to methods of making a polymerized color layer. | 2015-02-12 |
20150044152 | COSMETIC COMPOSITION FOR MAKE-UP CONTAINING SILICONE ELASTOMER - Disclosed is an elastic make-up cosmetic composition containing a silicone elastomer. More particularly, the make-up cosmetic composition includes a powder type silicone elastomer, powder extender pigment, hydrocarbon gel, anhydrous silicone oil and organic dispersant oil. A silicone elastomer of a surface-treated powder type and a polymer are used to improve the dispersibility of silicone elastomer when producing a cosmetic composition. As a result, it is possible to provide a make-up cosmetic composition having a silky and soft elastic feel. The resultant cosmetic composition is adhered to the skin smoothly, has a good elastic feel and spreadability and shows little dust flying. | 2015-02-12 |
20150044153 | SOFT SOLID ANTIPERSPIRANT DEODORANT COMPOSITION - Antiperspirant deodorant compositions and method for making the same apparatus are provided. The antiperspirant deodorant composition includes structurants and an emulsifier wherein the structurants include microcrystalline wax and paraffin wax. | 2015-02-12 |
20150044154 | COMPOSITION FOR THE TREATMENT OF KERATINOUS FIBERS COMPRISING AT LEAST ONE FIXING POLYMER AND AT LEAST ONE COMPOUND OF THE CERAMIDE TYPE AND METHODS FOR USING THE COMPOSITION - The invention relates to a cosmetic composition for the treatment of keratinous fibres, in particular human hair, comprising at least one anionic, nonionic, amphoteric or zwitterionic fixing polymer and at least one compound of the ceramide type as well as to the method of treatment using this composition. | 2015-02-12 |
20150044155 | HAIR PREPARATIONS COMPRISING HYDROXY-TERMINATED ORGANOPOLYSILOXANE(S) AND CONDITIONER(S) - Cosmetic compositions which contain at least one conditioning agent selected from synthetic oils, mineral oils, plant oils, fluorinated or perfluorinated oils, natural or synthetic waxes, compounds of the ceramide type, carboxylic acid esters, silicones differing from the silicones of formulae (I), anionic polymers, nonionic polymers, cationic polymers, amphoteric polymers, cationic proteins, cationic protein hydrolysates, cationic interfacially active substances and mixtures thereof and at least one hydroxy-terminated organopolysiloxane of formula (I). The cosmetic compositions improve numerous properties of the body surfaces, in particular hair, treated therewith and, in addition to improved combability and improved handle, in particular lead to a reduction in the contact angle of the hair. | 2015-02-12 |
20150044156 | HAIR PREPARATIONS COMPRISING HYDROXY-TERMINATED ORGANOPOLYSILOXANE(S) AND THICKENER(S) - Cosmetic compositions include at least one thickener selected from associative thickeners; crosslinked homopolymers of acrylic acid; crosslinked copolymers of (meth)acrylic acid and alkyl(C | 2015-02-12 |
20150044157 | SULFATE-FREE STRUCTURED LIQUID SURFACTANTS - An aqueous structured surfactant composition comprising water, one or more sulfate free anionic surfactants, one or more hydroxysultaines and one or more amphodiacetates, which is capable of suspending water insoluble or partially water soluble components. A sulfate-free structured liquid surfactant composition for use in personal care formulations allows for high level of vegetable oil and/or fragrance oil in end formula without negatively affecting stability and foam properties. | 2015-02-12 |
20150044158 | METHIONYL-METHIONINE STEREOISOMERS AND USE THEREOF IN COSMETICS - The present invention relates to a cosmetic formulation comprising certain methionyl-methionine stereoisomers and to the use of methionyl-methionine for nail and/or hair treatment. | 2015-02-12 |
20150044159 | MALODOR CONTROL COMPOSITION FOR USE IN-HOME COMPOSTING - The use of a malodor control composition in a home composting appliance helps to eliminate malodor emitting from compostable materials contained in the appliance during the composting process. | 2015-02-12 |
20150044160 | PROTEIN-POLYMER-DRUG CONJUGATES - A drug conjugate is provided herein. The conjugate comprises a protein based recognition-molecule (PBRM) and a polymeric carrier substituted with one or more -L | 2015-02-12 |
20150044161 | MULTIFUNCTIONAL POLYMERS - Described herein are multifunctional polymers comprising a first repeating unit having at least one pseudo-cationic moiety, a second repeating unit having at least a hydrophobic moiety, and a third repeating unit, where the weight-average molecular weight is less than about 10,000 Da. In one embodiment the polymers exhibit antimicrobial activity. Also provided are compositions formulated with the multifunctional polymers, and a method of providing antimicrobial activity. | 2015-02-12 |
20150044162 | ANTICANCER FUSION PROTEIN - A fusion protein comprising domain (a) which is a functional fragment of hTRAIL protein sequence, which fragment begins with an amino acid at a position not lower than hTRAIL95, or a homolog of said functional fragment having at least 70% sequence identity, preferably 85% identity and ending with the amino acid hTRAIL281; and domain (b) which is a sequence of an effector peptide inhibiting protein synthesis, wherein the sequence of domain (b) is attached at the C-terminus or N-terminus of domain (a). The fusion protein can be used for the treatment of cancer diseases. | 2015-02-12 |
20150044163 | A Method for Cuticle Growth using Granulocyte-Colony Stimulating Factor - The present invention provides a method for re-growing hair in patients with androgenic alopecia by administering effective consecutive courses of Granulocyte-Colony Stimulating Factor or derivatives. After the state of re-growth is obtained, the hair growth is maintained by administering periodic courses of Granulocyte-Colony Stimulating Factor or derivatives. The invention further provides a method for increasing cuticle growth and density using a similar administration of effective consecutive courses of Granulocyte-Colony Stimulating Factor or derivatives. The increased cuticle growth and density is maintained by administering periodic courses of Granulocyte-Colony Stimulating Factor or derivatives. | 2015-02-12 |
20150044164 | Methods of Treating Autoimmune Diseases - Novel methods for treating patients with autoimmune diseases are disclosed. The methods of the invention include first depleting circulating lymphocytes in the mammal, e.g., by administering anti-thymocyte antibody, and then, during the course of repopulation, administering to the mammal a therapeutically effective amount of latent TGF-β and/or another agent that promotes expansion of regulatory T cells. In certain aspects, the disclosed process results in improved kidney function and survival rates. | 2015-02-12 |
20150044165 | COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET - The invention features methods of diagnosis by assessing B7-H1 expression in a tissue from a subject that has, or is suspected of having, cancer, methods of treatment with agents that interfere with B7-H1-receptor interaction, methods of selecting candidate subjects likely to benefit from cancer immunotherapy, and methods of inhibiting expression of B7-H1. | 2015-02-12 |
20150044166 | COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX - Methods, compositions, and medical device systems relating to treating exercise-induced pulmonary hemorrhage (EIPH) and nasopharyngeal cicatrix (NC) in a mammal. For example, one method comprises administering through inhalation a composition comprising a physiologically acceptable carrier and an effective amount of each of one or more stem cell derived factors. Exemplary stem cell derived factors include, but are not limited to, growth factors, chemokines, and cytokines. The mammal may be a horse, dog, camel, or | 2015-02-12 |
20150044167 | Means and Method for Response Prediction of Hepatitis B Treatment - The present invention provides means and methods for determining whether a hepatitis B patient is susceptible to hepatitis B treatment, comprising determining whether a sample of the patient comprises nucleic acid with nucleotide polymorphisms that are associated with a positive outcome of hepatitis B treatment and/or determining whether a sample of the patient comprises an expression level of carnitine or of a carnitine derivative that is associated with a positive outcome of hepatitis B treatment. Compositions, kits of parts, (micro)arrays and vectors useful for such methods are also herewith provided. | 2015-02-12 |
20150044168 | Treatment of Multiple Sclerosis With Anti-CD19 Antibody - The present invention provides for the treatment of multiple sclerosis through the use of chimeric and humanized versions of anti-CD19 antibodies that may mediate ADCC, CDC, and/or apoptosis. | 2015-02-12 |
20150044169 | METHODS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, AND SCREENING ASSAYS FOR IDENTIFYING COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION - Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of identifying a candidate agent for the treatment of hepatitis C virus (HCV) infection, and the like. | 2015-02-12 |
20150044170 | EXPRESSION OF VIRUS ENTRY INHIBITORS AND RECOMBINANT AAV THEREFOR - The present invention relates generally to the use of recombinant adeno-associated viruses (rAAV) for gene delivery and more specifically to the use of rAAV to deliver genes encoding human immunodeficiency virus entry inhibitors to target cells in mammals. | 2015-02-12 |
20150044171 | Gain-of-Function ADAMTS13 Variants Resistant to Auto Antibody Inhibition and Methods of Use Thereof - Compositions and methods for the treatment of thrombotic thrombocytopenic purpura are disclosed. | 2015-02-12 |
20150044172 | PROBIOTIC COMPOSITIONS AND METHODS - The present invention relates to probiotic compositions and methods of using such compositions. In particular, the present invention provides method of using | 2015-02-12 |
20150044173 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE - Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag. | 2015-02-12 |
20150044174 | COMPOSITION FOR IMPROVING EYE HEALTH - The present invention relates to a composition for promoting eye health in a companion animal. The composition comprising: at least one polyphenol selected from the group consisting of rosemary, rosemary extract, coffeic acid, coffee extract, turmeric extract, cucurmin, blueberry extract, grapeseed extract, rosemarinic acid, tea extract, and mixtures thereof. | 2015-02-12 |
20150044175 | Bacteriophage preparations and methods of use thereof - Disclosed herein are purified bacteriophage preparations that effectively lyse a plurality of | 2015-02-12 |
20150044176 | STEM CELL CULTURE MEDIA AND METHODS OF ENHANCING CELL SURVIVIAL - The invention provides improved methods for preparing hematopoietic cells for transplantation and the resulting improved hematopoietic cell compositions. The invention further relates to improved culture media and methods of culturing, processing, modulating, and expanding blood cell products for hematopoietic transplantation. | 2015-02-12 |
20150044177 | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PLACENTAL STEM CELLS - Provided herein are methods of treatment of an individual having amyotrophic lateral sclerosis, comprising administering to the individual a therapeutically effective amount of placental stem cells, e.g., tissue culture surface-adherent placental stem cells (PDACs). In one aspect, provided herein is a method of treating amyotrophic lateral sclerosis (ALS) comprising administering to an individual having ALS a therapeutically effective amount of placental stem cells. In certain embodiments, “therapeutically effective” means an amount effective to reduce or ameliorate one or more symptoms of ALS. | 2015-02-12 |
20150044178 | NORMALIZATION OF CULTURE OF CORNEAL ENDOTHELIAL CELLS - The present invention provides a method for the normalized culturing of corneal endothelial cells. More specifically, the present invention provides a culture-normalizing-agent of a corneal endothelial cell, comprising a fibrosis inhibitor. In detail, the present invention provides a culture-normalizing agent comprising a transforming growth factor (TGF) β signal inhibitor. The present invention also provides a culture medium for culturing a corneal endothelial cell normally, which comprises the culture-normalizing agent according to the present invention and corneal endothelium culture components. The present invention also provides a method for culturing a corneal endothelial cell normally, comprising the step of culturing a corneal endothelial cell using the culture-normalizing agent according to the present invention or the culture medium according to the present invention. | 2015-02-12 |
20150044179 | CELL PREPARATION INCLUDING FAT CELL - A main objective of the present invention is to provide a cell preparation useful for treatment of diseases in bone joints and repairing muscles which have been degenerated or damaged. The present invention provides a cell preparation for treatment of diseases in bone joints which comprises a fat cell, and a cell preparation for repairing muscles which comprises a fat cell and a mesodermal stem cell. | 2015-02-12 |
20150044180 | ISOLATION AND USE OF PLURIPOTENT STEM CELL POPULATION FROM ADULT NEURAL CREST-DERIVED TISSUES - The present invention relates to methods of isolating a substantially homogeneous population of pluripotent stem cells from adult neural crest tissue (e.g., periodontal ligament) as well as pharmaceutical compositions comprising such isolated pluripotent stem cells. Methods of inducing the isolated pluripotent stem cells into specific cell lineages, such as neurogenic and retinogenic lineages, are also described. The isolated pluripotent stem cells find use in various regenerative medicine applications and the treatment of degenerative diseases. | 2015-02-12 |
20150044181 | IDENTIFICATION OF CHANNELRHODOPSIN-2 (CHR2) MUTATIONS AND METHODS OF USE - The invention provides compositions and kits including at least one nucleic acid or polypeptide molecule encoding for a mutant ChR2 protein. Methods of the invention include administering a composition comprising a mutant ChR2 to a subject to preserve, improve, or restore phototransduction. Preferably, the compositions and methods of the invention are provided to a subject having impaired vision, thereby restoring vision to normal levels. | 2015-02-12 |
20150044182 | DEVICES AND METHODS FOR SELECTING APOPTOSIS-SIGNALING RESISTANT CELLS, AND USES THEREOF - The present invention discloses a device and a kit adapted for selection of cells that are resistant to receptor-mediated apoptosis and a method for using the device and kit. The device enables negative selection of mature immune cells which induce graft versus host disease (GvHD) out of a heterogeneous cell population which is introduced into the device. The device enables an efficient cell selection in simplified and cheaper setting by an off the shelf product—a solution that currently do not exist. The present invention further discloses uses for the device. | 2015-02-12 |